Clinical Trial Update: Trial to Determine Effective Aspirin Dose in COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Johns Hopkins University is evaluating the effective aspirin dose in chronic obstructive pulmonary disease and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: RECRUITING